Moreover, distinct biological mechanisms, such as the unique effects of lipid metabolism dysregulation on cellular pathways like Akt and mTOR, may further explain why dyslipidemia differs mechanistically from diabetes, hypertension, and obesity [46, 47]. This evidence concerns the gene AKT1 and hypertensive disorder.